REFERENCES
Bellamy, R. J., and A. R. Freedman. Bioterrorism. QJM 94(4):227–234, 2001.
Buehler, J. W., R. L. Berkelman, D. M. Hartley, and C. J. Peters. Syndromic surveillance and bioterrorism-related epidemics. Emerg. Infect. Dis. 9(10):1197–1204, 2003.
Centers for Disease Control and Prevention. Recognition of illness associated with the intentional release of a biologic agent. JAMA 286(17):2088–2090, 2001.
Cherry, C. L., M. A. Kainer, and T. A. Ruff. Biological weapons preparedness: The role of physicians. Intern. Med. J. 33(5–6):242–253, 2003.
Johnson, N. P., and J. Mueller. Updating the accounts: Global mortality of the 1918–1920 “Spanish” influenza pandemic. Bull. Hist. Med. 76:105–115, 2002.
Lavanchy, D. Public health measures in the control of viral hepatitis: A World Health Organization perspective for the next millennium. J. Gastroenterol. Hepatol. 17:S452–S459, 2002.
Lederberg, J. Infectious history. Science 288(5464):287–293, 2000.
Sintchak, M. D., and E. Nimmesgern. The structure of inosine 5′-monophosphate dehydrogenase and the design of novel inhibitors. Immunopharmacology. 47(2–3):163–184, 2000.
Taubenberger, J. K., and D. M. Morens. 1918 influenza: The mother of all pandemics. Emerg. Infect. Dis. 12(1):15–22, 2006.
World Health Organization. Removing Obstacles to Healthy Development. World Health Organization, Geneva, 1999.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Stein, R.A. Antiviral Drug Discovery for Emerging Diseases and Bioterrorism Threats. Edited by Paul F. Torrence, John Wiley and Sons Inc., Hoboken, NJ, 2005, x + 420 pp. ISBN 0-471-66827-3. Ann Biomed Eng 34, 1503–1504 (2006). https://doi.org/10.1007/s10439-006-9166-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10439-006-9166-9